138 related articles for article (PubMed ID: 35337911)
81. In vitro digestion of edible nanostructured lipid carriers: Impact of a Candelilla wax gelator on performance.
Sislioglu K; Gumus CE; Koo CKW; Karabulut I; McClements DJ
Food Res Int; 2021 Feb; 140():110060. PubMed ID: 33648283
[TBL] [Abstract][Full Text] [Related]
82. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
83. Fabrication of curcumin-loaded oleogels using camellia oil bodies and gum arabic/chitosan coatings for controlled release applications.
Farooq S; Ahmad MI; Ali U; Zhang H
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127758. PubMed ID: 38287596
[TBL] [Abstract][Full Text] [Related]
84. Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption.
Kadry H; Al-Hilal TA; Keshavarz A; Alam F; Xu C; Joy A; Ahsan F
Int J Pharm; 2018 Jun; 544(1):285-296. PubMed ID: 29680281
[TBL] [Abstract][Full Text] [Related]
85. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
86. Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.
Woraphatphadung T; Sajomsang W; Rojanarata T; Ngawhirunpat T; Tonglairoum P; Opanasopit P
AAPS PharmSciTech; 2018 Apr; 19(3):991-1000. PubMed ID: 29110292
[TBL] [Abstract][Full Text] [Related]
87. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs.
Ni J; Tian F; Dahmani FZ; Yang H; Yue D; He S; Zhou J; Yao J
Drug Deliv; 2016 Nov; 23(9):3424-3435. PubMed ID: 27198856
[TBL] [Abstract][Full Text] [Related]
88. Developing and optimizing low-saturated oleogel shortening based on ethyl cellulose and hydroxypropyl methyl cellulose biopolymers.
Naeli MH; Milani JM; Farmani J; Zargaraan A
Food Chem; 2022 Feb; 369():130963. PubMed ID: 34479005
[TBL] [Abstract][Full Text] [Related]
89. Toward a Platform for the Treatment of Burns: An Assessment of Nanoemulsions vs. Nanostructured Lipid Carriers Loaded with Curcumin.
Araújo GMS; Loureiro AIS; Rodrigues JL; Barros PAB; Halicki PCB; Ramos DF; Marinho MAG; Vaiss DP; Vaz GR; Yurgel VC; Bidone J; Muccillo-Baisch AL; Hort MA; Paulo AMC; Dora CL
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137569
[TBL] [Abstract][Full Text] [Related]
90. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
[TBL] [Abstract][Full Text] [Related]
91. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
[TBL] [Abstract][Full Text] [Related]
92. Storage stability and solubilization ability of HPMC in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Ma P; Wang X; Li C; Zhang X; Zhang K; Li J; He Z
Carbohydr Polym; 2018 Nov; 199():492-498. PubMed ID: 30143154
[TBL] [Abstract][Full Text] [Related]
93. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
Fan X; Chen J; Shen Q
Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
[TBL] [Abstract][Full Text] [Related]
94. Transferrin-functionalized lipid nanoparticles for curcumin brain delivery.
Neves AR; van der Putten L; Queiroz JF; Pinheiro M; Reis S
J Biotechnol; 2021 Apr; 331():108-117. PubMed ID: 33727082
[TBL] [Abstract][Full Text] [Related]
95. The enhancement of N-acetylcysteine on intestinal absorption and oral bioavailability of hydrophobic curcumin.
Zhang S; Asghar S; Yu F; Hu Z; Ping Q; Chen Z; Shao F; Xiao Y
Eur J Pharm Sci; 2020 Nov; 154():105506. PubMed ID: 32763460
[TBL] [Abstract][Full Text] [Related]
96. Lactoferrin particles assembled via transglutaminase-induced crosslinking: Utilization in oleogel-based Pickering emulsions with improved curcumin bioaccessibility.
Xia T; Gao Y; Liu Y; Wei Z; Xue C
Food Chem; 2022 Apr; 374():131779. PubMed ID: 34896951
[TBL] [Abstract][Full Text] [Related]
97. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
98. Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells.
Varshosaz J; Jandaghian S; Mirian M; Sajjadi SE
J Liposome Res; 2021 Mar; 31(1):64-78. PubMed ID: 32138557
[TBL] [Abstract][Full Text] [Related]
99. The effect of HPMC--a cholesterol-lowering agent--on oral drug absorption in dogs.
Reppas C; Eleftheriou G; Macheras P; Symillides M; Greenwood D; Dressman JB
Biopharm Drug Dispos; 1998 Nov; 19(8):523-30. PubMed ID: 9840214
[TBL] [Abstract][Full Text] [Related]
100. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
